A phase I/II study of S-1 with sorafenib in patients with advanced hepatocellular carcinoma.

MLA

Ooka, Yoshihiko, et al. “A Phase I/II Study of S-1 with Sorafenib in Patients with Advanced Hepatocellular Carcinoma.” Investigational New Drugs, vol. 32, no. 4, Aug. 2014, pp. 723–28. EBSCOhost, https://doi.org/10.1007/s10637-014-0077-6.

APA

Ooka, Y., Chiba, T., Ogasawara, S., Arai, K., Suzuki, E., Tawada, A., Yamashita, T., Kanai, F., Kaneko, S., & Yokosuka, O. (2014). A phase I/II study of S-1 with sorafenib in patients with advanced hepatocellular carcinoma. Investigational New Drugs, 32(4), 723–728. https://doi.org/10.1007/s10637-014-0077-6

Chicago

Ooka, Yoshihiko, Tetsuhiro Chiba, Sadahisa Ogasawara, Kuniaki Arai, Eiichiro Suzuki, Akinobu Tawada, Tatsuya Yamashita, Fumihiko Kanai, Shuichi Kaneko, and Osamu Yokosuka. 2014. “A Phase I/II Study of S-1 with Sorafenib in Patients with Advanced Hepatocellular Carcinoma.” Investigational New Drugs 32 (4): 723–28. doi:10.1007/s10637-014-0077-6.